Correlation Between AstraZeneca PLC and Mayne Pharma
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Mayne Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Mayne Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and Mayne Pharma Group, you can compare the effects of market volatilities on AstraZeneca PLC and Mayne Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Mayne Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Mayne Pharma.
Diversification Opportunities for AstraZeneca PLC and Mayne Pharma
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AstraZeneca and Mayne is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and Mayne Pharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mayne Pharma Group and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with Mayne Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mayne Pharma Group has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Mayne Pharma go up and down completely randomly.
Pair Corralation between AstraZeneca PLC and Mayne Pharma
Considering the 90-day investment horizon AstraZeneca PLC is expected to generate 1.48 times less return on investment than Mayne Pharma. But when comparing it to its historical volatility, AstraZeneca PLC ADR is 2.3 times less risky than Mayne Pharma. It trades about 0.1 of its potential returns per unit of risk. Mayne Pharma Group is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 300.00 in Mayne Pharma Group on September 13, 2024 and sell it today you would earn a total of 10.00 from holding Mayne Pharma Group or generate 3.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AstraZeneca PLC ADR vs. Mayne Pharma Group
Performance |
| Timeline |
| AstraZeneca PLC ADR |
| Mayne Pharma Group |
AstraZeneca PLC and Mayne Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AstraZeneca PLC and Mayne Pharma
The main advantage of trading using opposite AstraZeneca PLC and Mayne Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Mayne Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mayne Pharma will offset losses from the drop in Mayne Pharma's long position.| AstraZeneca PLC vs. Novartis AG ADR | AstraZeneca PLC vs. GlaxoSmithKline PLC ADR | AstraZeneca PLC vs. Roche Holding Ltd | AstraZeneca PLC vs. Bristol Myers Squibb |
| Mayne Pharma vs. Bristol Myers Squibb | Mayne Pharma vs. AbbVie Inc | Mayne Pharma vs. Merck Company | Mayne Pharma vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |